Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.
Luciana MidagliaÀlex RoviraBerta MiróJordi RíoNicolás FissoloJoaquín CastillóAlex SánchezXavier MontalbanManuel Comabella LopezPublished in: European journal of neurology (2023)
Magnetic resonance imaging phenotypes defined by inflammation and neurodegeneration correlate with serum biomarker levels, and both have prognostic implications in treatment response and long-term disease outcomes.
Keyphrases
- magnetic resonance imaging
- multiple sclerosis
- end stage renal disease
- computed tomography
- ejection fraction
- newly diagnosed
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- contrast enhanced
- prognostic factors
- type diabetes
- metabolic syndrome
- patient reported
- insulin resistance
- glycemic control
- weight loss